SCHEMBL14060422

SCHEMBL14060422

COc1ccc2cc(C(N)=S)ccc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
RAD52 P43351 1/20 0.53
CYP1A2 P05177 2/20 0.50
CYP2A6 P11509 2/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HPGDS O60760 1/20 0.47
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
PARP1 P09874 1/20 0.47
PARP10 Q53GL7 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
PARP4 Q9UKK3 1/20 0.47
PLAU P00749 2/20 0.46
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201860 0.81 CA1 (0.61) ALDH1A1HPGDRAD52PRSS1PRSS2
SCHEMBL9702109 0.81 KDM4E (0.70) KDM4EALDH1A1HPGDCYP1A2CYP2A6
SCHEMBL3368290 0.81 PRSS1 (0.68) KDM4EALDH1A1HPGDCYP1A2CYP2A6
SCHEMBL31546801 0.81 PRSS1 (0.68) KDM4EALDH1A1HPGDCYP1A2CYP2A6
Hydrochloric Acid SCHEMBL31546705 0.79 PRSS1 (0.66) KDM4EPRSS1PRSS2PRSS3PLAU
SCHEMBL29500266 0.78 PARP1 (0.67) ALDH1A1HPGDRAD52PRSS1PRSS2
SCHEMBL2888543 0.78 PARP1 (0.67) ALDH1A1HPGDRAD52PRSS1PRSS2
SCHEMBL23864974 0.78 KDM4E (0.56) KDM4EALDH1A1HPGDCYP1A2CYP2A6
SCHEMBL11810869 0.76 KDM4E (0.75) KDM4EALDH1A1HPGDCYP1A2CYP2A6
SCHEMBL17288621 0.76 KDM4E (0.63) KDM4EALDH1A1HPGDCYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714682-B1 NOVEL TETRAHYDROISOQUINOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITÀ DEGLI STUDI DI BARI ALDO MORO (IT) 2016-03-16 EP disclosed
US-9095631-B2 Tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases UNIVERSITA DEGLI STUDI DI BARI “ALDO MORO” (IT) 2015-08-04 US disclosed
US-9095631-B2 Tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases UNIVERSITA DEGLI STUDI DI BARI “ALDO MORO” (IT) 2015-08-04 US disclosed
US-9095631-B2 Tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases UNIVERSITA DEGLI STUDI DI BARI “ALDO MORO” (IT) 2015-08-04 US disclosed
US-20140112868-A1 NOVEL TETRAHYDROISOQUINOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITA' DEGLI STUDI DI BARI "ALDO MORO" (IT) 2014-04-24 US disclosed
WO-2012159666-A1 NOVEL TETRAHYDROISOQUINOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITA' DEGLI STUDI DI BARI (IT) 2012-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140112868-A1 NOVEL TETRAHYDROISOQUINOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES ABCB1, ABCG2, ABCC2 KDM4E 4182/4885ALDH1A1 1718/4885HPGD 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.